Sone-296 Page

A brief, one‑paragraph summary that states:

| Parameter | Details | |-----------|---------| | Study design | Open‑label, dose‑escalation (3 + 3), followed by expansion cohorts. | | Population | Adults with advanced solid tumors refractory to standard therapy. | | Dose range | 5 mg – 200 mg QD oral. | | Primary endpoints | Safety/tolerability, MTD, pharmacokinetics. | | Key secondary endpoints | Preliminary efficacy (RECIST response), pharmacodynamics (target inhibition in tumor biopsies). | | Status | Completed (2024); MTD = 150 mg QD, RP2D = 120 mg QD. |

Key findings (if publicly disclosed)

SONE‑296: A Next‑Generation Small‑Molecule Modulator of the SONE Pathway – Mechanism, Pre‑Clinical Data, and Clinical Outlook

If you want, I can convert this into a ready-to-attach ticket template (with specific fields, estimated story points, and a checklist) or generate API schema examples and DB migration SQL for SONE-296. Which would you prefer? SONE-296

Covers legal proceedings regarding the transfer of lands held in trust by persons under disability, specifically regarding the sale or conveyance of property [source: Wisconsin Statutes, docs.legis.wisconsin.gov]. Washington WAC 296-155:

Covers safety standards for construction work, often updated regarding hazardous substances or machinery [source: Washington Legislature, app.leg.wa.gov]. A brief, one‑paragraph summary that states:

If this is not the specific "proper paper" you are looking for, please provide more context (e.g., medical, legal, or technical) for a more precise search.

AI responses may include mistakes. For legal advice, consult a professional. Learn more | Parameter | Details | |-----------|---------| | Study

Assuming SONE-296 could be a placeholder for a hypothetical model or project you're working on, I'll provide a general guide on how to approach feature generation for a project: